Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Am J Ophthalmol. 2023 Jul 5;254:221–232. doi: 10.1016/j.ajo.2023.06.021

Figure 1:

Figure 1:

Cataract-free survival with 95% Confidence Limits, among eyes with anterior uveitis from the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. The overall incidence of cataract (the first-occurring of cataract surgery or reduction in visual acuity worse than 20/40 primarily attributed to cataract) was 0.054/eye-year, 95% confidence interval, 0.049–0.059.